Balkan Journal of Medical Genetics

VALUE OF OPTICAL GENOME MAPPING (OGM) FOR DIAGNOSTICS OF RARE DISEASES: A FAMILY CASE REPORT
Kovanda A1,2, Miljanović O3, Lovrečić L1,2, Maver A1,2, Hodžić A1,2, Peterlin B1,2,*
*Corresponding Author: *Corresponding Author: Prof. Borut Peterlin, Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, Šlajmerjeva 4, 1000 Ljubljana, Slovenia. borut.peterlin@kclj.si
page: 87

REFERENCES

1. Dremsek P, Schwarz T, Weil B, Malashka A, Laccone F, Neesen J. Optical Genome Mapping in Routine Human Genetic Diagnostics—Its Advantages and Limitations. Genes. 2021;12(12):1958. doi:10.3390/ genes12121958 2. Mantere T, Neveling K, Pebrel-Richard C, et al. Optical genome mapping enables constitutional chromosomal aberration detection. Am J Hum Genet. 2021;108(8):1409-1422. doi:10.1016/j. ajhg.2021.05.012 3. Levy B, Baughn LB, Akkari Y, et al. Optical ge- nome mapping in acute myeloid leukemia: a multi- center evaluation. Blood Adv. 2023;7(7):1297-1307. doi:10.1182/bloodadvances.2022007583 4. Coccaro N, Anelli L, Zagaria A, et al. Feasibility of Optical Genome Mapping in Cytogenetic Diagnos- tics of Hematological Neoplasms: A New Way to Look at DNA. Diagn Basel Switz. 2023;13(11):1841. doi:10.3390/diagnostics13111841 5. Giguère A, Raymond-Bouchard I, Collin V, Claveau JS, Hébert J, LeBlanc R. Optical Genome Mapping Reveals the Complex Genetic Landscape of My- eloma. Cancers. 2023;15(19):4687. doi:10.3390/ cancers15194687 6. Puiggros A, Ramos-Campoy S, Kamaso J, et al. Op- tical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lympho- cytic Leukemia (CLL). Cancers. 2022;14(14):3376. doi:10.3390/cancers14143376 7. Tsai HH, Kao HJ, Kuo MW, et al. Whole genomic analysis reveals atypical non-homologous off-tar- get large structural variants induced by CRISPR- Cas9-mediated genome editing. Nat Commun. 2023;14(1):5183. doi:10.1038/s41467-023-40901-x 8. Zhang Q, Xu X, Ding L, et al. Clinical application of single‐molecule optical mapping to a multigen- eration FSHD1 pedigree. Mol Genet Genomic Med. 2019;7(3):e565. doi:10.1002/mgg3.565 9. Stence AA, Thomason JG, Pruessner JA, et al. Valida- tion of Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dys- trophy. J Mol Diagn JMD. 2021;23(11):1506-1514. doi:10.1016/j.jmoldx.2021.07.021 10. Efthymiou S, Lemmers RJLF, Vishnu VY, et al. Optical Genome Mapping for the Molecular Di- agnosis of Facioscapulohumeral Muscular Dystro- phy: Advancement and Challenges. Biomolecules. 2023;13(11):1567. doi:10.3390/biom13111567 11. Kovanda A, Lovrečić L, Rudolf G, et al. Evalua- tion of Optical Genome Mapping in Clinical Ge- netic Testing of Facioscapulohumeral Muscular Dystrophy. Genetic and Genomic Medicine; 2023. doi:10.1101/2023.08.10.23292816 12. Rogac M, Kovanda A, Lovrečić L, Peterlin B. Optical genome mapping in an atypical Pelizaeus-Merzbach- er prenatal challenge. Front Genet. 2023;14:1173426. doi:10.3389/fgene.2023.1173426 13. Ales M, Luca L, Marija V, et al. Phenotype-driven gene target definition in clinical genome-wide sequencing data interpretation. Genet Med. 2016;18(11):1102- 1110. doi:10.1038/gim.2016.22 14. Bergant G, Maver A, Lovrecic L, Čuturilo G, Hodzic A, Peterlin B. Comprehensive use of extended exome analysis improves diagnostic yield in rare disease: a retrospective survey in 1,059 cases. Genet Med. 2018;20(3):303-312. doi:10.1038/gim.2017.142 15. Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of con- stitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med Off J Am Coll Med Genet. 2020;22(2):245-257. doi:10.1038/ s41436-019-0686-8 16. MacDonald JR, Ziman R, Yuen RKC, Feuk L, Scherer SW. The Database of Genomic Variants: a curated collection of structural variation in the hu- man genome. Nucleic Acids Res. 2014;42(Database issue):D986-992. doi:10.1093/nar/gkt958 17. Moore S, McGowan-Jordan J, Smith AC, et al. Ge- nome Mapping Nomenclature. Cytogenet Genome Res. 2023;163(5-6):236-246. doi:10.1159/000535684 18. The GIMP Development Team. GIMP. Published online June 12, 2019. https://www.gimp.org 19. Phillips-Cremins JE, Corces VG. Chromatin Insula- tors: Linking Genome Organization to Cellular Func- tion. Mol Cell. 2013;50(4):461-474. doi:10.1016/j. molcel.2013.04.018 20. van Steensel B, Belmont AS. Lamina-Associated Domains: Links with Chromosome Architecture, Heterochromatin, and Gene Repression. Cell. 2017;169(5):780-791. doi:10.1016/j.cell.2017.04.022 21. Huang H, Zhu Q, Jussila A, et al. CTCF mediates dos- age- and sequence-context-dependent transcriptional insulation by forming local chromatin domains. Nat Genet. 2021;53(7):1064-1074. doi:10.1038/s41588- 021-00863-6 22. Hong CKY, Cohen BA. Genomic environments scale the activities of diverse core promoters. Genome Res. 2022;32(1):85-96. doi:10.1101/gr.276025.121 23. Nassar LR, Barber GP, Benet-Pagès A, et al. The UCSC Genome Browser database: 2023 update. Nucleic Acids Res. 2023;51(D1):D1188-D1195. doi:10.1093/nar/gkac1072 24. Fjorder AS, Rasmussen MB, Mehrjouy MM, et al. Haploinsufficiency of ARHGAP42 is associ- ated with hypertension. Eur J Hum Genet EJHG. 2019;27(8):1296-1303. doi:10.1038/s41431-019- 0382-9 25. Nagao K, Ito H, Yoshida H. Chromosomal transloca- tion t(X;18) in human synovial sarcomas analyzed by fluorescence in situ hybridization using paraffin- embedded tissue. Am J Pathol. 1996;148(2):601-609. 26. Udayakumar AM, Sundareshan TS, Mukherjee G, Biswas S, Rajan KR, Prabhakaran PS. Submandibular synovial sarcoma with t(X;18) and synovial sarcoma of the toe with additional cytogenetic abnormalities. Cancer Genet Cytogenet. 2002;134(2):151-155. doi:10.1016/S0165-4608(01)00606-9 27. The ACMG Laboratory Quality Assurance Commit- tee, Richards S, Aziz N, et al. Standards and guide- lines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-423. doi:10.1038/gim.2015.30

Number 27 VOL. 27 (2), 2024	Number 27 VOL. 27 (1), 2024
Number 26 Number 26 VOL. 26(2), 2023 All in one	Number 26 VOL. 26(2), 2023
Number 26 VOL. 26, 2023 Supplement	Number 26 VOL. 26(1), 2023
Number 25 VOL. 25(2), 2022	Number 25 VOL. 25 (1), 2022
Number 24 VOL. 24(2), 2021	Number 24 VOL. 24(1), 2021
Number 23 VOL. 23(2), 2020	Number 22 VOL. 22(2), 2019
Number 22 VOL. 22(1), 2019	Number 22 VOL. 22, 2019 Supplement
Number 21 VOL. 21(2), 2018	Number 21 VOL. 21 (1), 2018
Number 21 VOL. 21, 2018 Supplement	Number 20 VOL. 20 (2), 2017
Number 20 VOL. 20 (1), 2017	Number 19 VOL. 19 (2), 2016
Number 19 VOL. 19 (1), 2016	Number 18 VOL. 18 (2), 2015
Number 18 VOL. 18 (1), 2015	Number 17 VOL. 17 (2), 2014
Number 17 VOL. 17 (1), 2014	Number 16 VOL. 16 (2), 2013
Number 16 VOL. 16 (1), 2013	Number 15 VOL. 15 (2), 2012
Number 15 VOL. 15, 2012 Supplement	Number 15 Vol. 15 (1), 2012
Number 14 14 - Vol. 14 (2), 2011	Number 14 The 9th Balkan Congress of Medical Genetics
Number 14 14 - Vol. 14 (1), 2011	Number 13 Vol. 13 (2), 2010
Number 13 Vol.13 (1), 2010	Number 12 Vol.12 (2), 2009
Number 12 Vol.12 (1), 2009	Number 11 Vol.11 (2),2008
Number 11 Vol.11 (1),2008	Number 10 Vol.10 (2), 2007
Number 10 10 (1),2007	Number 9 1&2, 2006
Number 9 3&4, 2006	Number 8 1&2, 2005
Number 8 3&4, 2004	Number 7 1&2, 2004
Number 6 3&4, 2003	Number 6 1&2, 2003
Number 5 3&4, 2002	Number 5 1&2, 2002
Number 4 Vol.3 (4), 2000	Number 4 Vol.2 (4), 1999
Number 4 Vol.1 (4), 1998	Number 4 3&4, 2001
Number 4 1&2, 2001	Number 3 Vol.3 (3), 2000
Number 3 Vol.2 (3), 1999	Number 3 Vol.1 (3), 1998
Number 2 Vol.3(2), 2000	Number 2 Vol.1 (2), 1998
Number 2 Vol.2 (2), 1999	Number 1 Vol.3 (1), 2000
Number 1 Vol.2 (1), 1999	Number 1 Vol.1 (1), 1998

About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact